TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype
Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Evangelista Sagnelli(University of Campania "Luigi Vanvitelli"), Patrizia Morelli(Vita-Salute San Raffaele University), Mario Starace(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Stefania Salpietro(IRCCS Ospedale San Raffaele), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Anna Grandone(University of Campania "Luigi Vanvitelli"), Emanuele Miraglia del Giudice(University of Campania "Luigi Vanvitelli"), Marco Merli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Carmine Minichini(University of Campania "Luigi Vanvitelli"), Grazia Cirillo(University of Campania "Luigi Vanvitelli"), Adriano Lazzarin(Vita-Salute San Raffaele University)
Cited by 10
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168